drugset / Trial / NCT04077671

CHF6467 SAD and MAD in Patients With Diabetic Foot Ulcer

NCT04077671 ↗

Phase 1/2 Completed 93 enrolled Chiesi Farmaceutici S.p.A. Comac Medical · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

To assess the safety and tolerability of single and multiple days' topical dosing with CHF6467 in subjects with diabetic foot ulcer (DFU).

Timeline

Start
2018-10-17
Primary completion
2021-01-07
Completion
2021-01-07

Drugs

EvaluationDrugModalityDoseRoute
Subject CHF6467 Protein / enzyme biologic 0.3 unknown Topical
Subject CHF6467 Protein / enzyme biologic 1 unknown Topical
Subject CHF6467 Protein / enzyme biologic 3 unknown Topical
Subject CHF6467 Protein / enzyme biologic 6 unknown Topical

Indications